Cargando…

The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients

SIMPLE SUMMARY: The etiology of the skin toxicity that is a common side effect of cetuximab is still under debate. In this study, proton nuclear magnetic resonance ((1)H-NMR) analysis of the sebum of 30 metastatic colorectal cancer patients, collected at different time points during cetuximab admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Saorin, Asia, Di Gregorio, Emanuela, Buonadonna, Angela, Miolo, Gianmaria, Corona, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656910/
https://www.ncbi.nlm.nih.gov/pubmed/36358726
http://dx.doi.org/10.3390/cancers14215308
_version_ 1784829557562408960
author Saorin, Asia
Di Gregorio, Emanuela
Buonadonna, Angela
Miolo, Gianmaria
Corona, Giuseppe
author_facet Saorin, Asia
Di Gregorio, Emanuela
Buonadonna, Angela
Miolo, Gianmaria
Corona, Giuseppe
author_sort Saorin, Asia
collection PubMed
description SIMPLE SUMMARY: The etiology of the skin toxicity that is a common side effect of cetuximab is still under debate. In this study, proton nuclear magnetic resonance ((1)H-NMR) analysis of the sebum of 30 metastatic colorectal cancer patients, collected at different time points during cetuximab administration, was performed. Both sebum production and composition were found to be affected by cetuximab treatment. These specific sebum lipid alterations could help to better understand the development of cetuximab-induced skin toxicity and could be useful for improving skin lesion prevention and treatments. ABSTRACT: The epidermal growth factor receptor inhibitor (EGFRIs) treatments are commonly associated with the development of adverse skin effects. This study aims to investigate the lipid composition change in sebum during cetuximab-based treatment in an attempt to identify specific metabolic signatures useful in predicting the occurrence of severe skin toxicity. Sebum from 30 metastatic colorectal cancer (mCRC) patients was collected at three time points during the targeted therapy by the application of Sebutape(®) on the forehead, and the major lipid classes were analyzed and quantified by (1)H-NMR. Univariate analysis was performed to reveal significant alterations among patients in sebum production as well as lipid composition and over the course of cetuximab therapy. A transient but significant decrease in sebum production associated with a reduction in the relative content of triglycerides (TG) and squalene (SQ) was found to be induced by cetuximab administration. The reduction of these two lipid classes was also found to be associated with the severity of skin rash experienced by patients. The results of this study indicate that cetuximab-based treatment can reduce sebum gland activity, leading to an overall decrease in sebum production and the induction of specific modifications to its composition. The extent of the loss of skin barrier function may be important for determining the severity of skin toxicity development.
format Online
Article
Text
id pubmed-9656910
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96569102022-11-15 The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients Saorin, Asia Di Gregorio, Emanuela Buonadonna, Angela Miolo, Gianmaria Corona, Giuseppe Cancers (Basel) Article SIMPLE SUMMARY: The etiology of the skin toxicity that is a common side effect of cetuximab is still under debate. In this study, proton nuclear magnetic resonance ((1)H-NMR) analysis of the sebum of 30 metastatic colorectal cancer patients, collected at different time points during cetuximab administration, was performed. Both sebum production and composition were found to be affected by cetuximab treatment. These specific sebum lipid alterations could help to better understand the development of cetuximab-induced skin toxicity and could be useful for improving skin lesion prevention and treatments. ABSTRACT: The epidermal growth factor receptor inhibitor (EGFRIs) treatments are commonly associated with the development of adverse skin effects. This study aims to investigate the lipid composition change in sebum during cetuximab-based treatment in an attempt to identify specific metabolic signatures useful in predicting the occurrence of severe skin toxicity. Sebum from 30 metastatic colorectal cancer (mCRC) patients was collected at three time points during the targeted therapy by the application of Sebutape(®) on the forehead, and the major lipid classes were analyzed and quantified by (1)H-NMR. Univariate analysis was performed to reveal significant alterations among patients in sebum production as well as lipid composition and over the course of cetuximab therapy. A transient but significant decrease in sebum production associated with a reduction in the relative content of triglycerides (TG) and squalene (SQ) was found to be induced by cetuximab administration. The reduction of these two lipid classes was also found to be associated with the severity of skin rash experienced by patients. The results of this study indicate that cetuximab-based treatment can reduce sebum gland activity, leading to an overall decrease in sebum production and the induction of specific modifications to its composition. The extent of the loss of skin barrier function may be important for determining the severity of skin toxicity development. MDPI 2022-10-28 /pmc/articles/PMC9656910/ /pubmed/36358726 http://dx.doi.org/10.3390/cancers14215308 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Saorin, Asia
Di Gregorio, Emanuela
Buonadonna, Angela
Miolo, Gianmaria
Corona, Giuseppe
The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
title The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
title_full The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
title_fullStr The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
title_full_unstemmed The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
title_short The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
title_sort riddle of cetuximab-related skin toxicity: (1)h-nmr sebum analysis revealed dynamic lipid alterations associated with skin toxicity development in metastatic colorectal cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656910/
https://www.ncbi.nlm.nih.gov/pubmed/36358726
http://dx.doi.org/10.3390/cancers14215308
work_keys_str_mv AT saorinasia theriddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT digregorioemanuela theriddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT buonadonnaangela theriddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT miologianmaria theriddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT coronagiuseppe theriddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT saorinasia riddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT digregorioemanuela riddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT buonadonnaangela riddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT miologianmaria riddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients
AT coronagiuseppe riddleofcetuximabrelatedskintoxicity1hnmrsebumanalysisrevealeddynamiclipidalterationsassociatedwithskintoxicitydevelopmentinmetastaticcolorectalcancerpatients